Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has shared an announcement.
Dawnrays Pharmaceutical Holdings Ltd. announced a special dividend of HKD 0.032 per share for the financial year ending December 31, 2024. This decision, approved by shareholders on May 23, 2025, reflects the company’s financial health and commitment to returning value to its stakeholders. The ex-dividend date is set for May 27, 2025, with payment scheduled for June 12, 2025. This move may enhance investor confidence and solidify the company’s position in the market.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company is primarily involved in providing medications and healthcare solutions, with a market focus on the Hong Kong region.
YTD Price Performance: 3.28%
Average Trading Volume: 171,535
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.89B
See more insights into 2348 stock on TipRanks’ Stock Analysis page.